Literature DB >> 3925865

Activities of antiplasmin and antiplasminogen activator in serous middle ear effusions.

Y Hamaguchi, M Ohi, Y Sakakura, Y Miyoshi.   

Abstract

Antiplasmin and antiplasminogen activator activities in serous middle ear effusion (MEE) collected from adult patients were measured to analyze the kinetics of antifibrinolytic activity of protease inhibitors. No trypsin, plasmin, and plasminogen activator (PA) activity could be detected in the pooled serous MEE by either the fibrin plate method or the fluorometric assay. Antiplasmin activity in serous MEE was lower than that in plasma. The MEE had no antiurokinase activity. These findings indicate that 1) serous MEE has residual antifibrinolytic activity which may be attributed to mainly antiplasmin activity of unsaturated plasmin inhibitors and not to anti-PA activity, and 2) that serous MEE contains no secretory urokinase inhibitors.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3925865

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  1 in total

1.  Multi-omic studies on missense PLG variants in families with otitis media.

Authors:  Tori C Bootpetch; Lena Hafrén; Christina L Elling; Erin E Baschal; Ani W Manichaikul; Harold S Pine; Wasyl Szeremeta; Melissa A Scholes; Stephen P Cass; Eric D Larson; Kenny H Chan; Rafaqat Ishaq; Jeremy D Prager; Rehan S Shaikh; Samuel P Gubbels; Ayesha Yousaf; Todd M Wine; Michael J Bamshad; Patricia J Yoon; Herman A Jenkins; Deborah A Nickerson; Sven-Olrik Streubel; Norman R Friedman; Daniel N Frank; Elisabet Einarsdottir; Juha Kere; Saima Riazuddin; Kathleen A Daly; Suzanne M Leal; Allen F Ryan; Petri S Mattila; Zubair M Ahmed; Michele M Sale; Tasnee Chonmaitree; Regie Lyn P Santos-Cortez
Journal:  Sci Rep       Date:  2020-09-14       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.